盐酸强力霉素 [盐酸多西环素]，Doxycycline hyclate；≥98% (HPLC), Calbiochem®

General description

A commonly used broad-spectrum antibiotic. A potent inhibitor of MMP-8 (neutrophil collagenase; IC₅₀ = 30 µM) relative to MMP-1 (collagenase-1; IC₅₀ = 300 µM). Also inhibits collagen synthesis by bovine articular chondrocytes cultured in alginate (IC₅₀ = 25 µM). Inhibits nitric oxide synthesis by LPS-activated macrophages without affecting IL-10 release.

A commonly-used broad-spectrum antibiotic. A potent inhibitor of MMP-8 (neutrophil collagenase; IC₅₀ = 30 µM) relative to MMP-1 (interstitial collagenase; IC₅₀ = 300 µM). Also inhibits collagen synthesis by bovine articular chondrocytes cultured in alginate (IC₅₀ = 25 µM). Inhibits nitric oxide synthesis by LPS-activated macrophages without affecting IL-10 release.

包装

1 g in Glass bottle

Biochem/physiol Actions

Cell permeable: no

Primary Target
MMP-8

Product does not compete with ATP.

Reversible: no

Target IC₅₀: 30 µM against MMP-8 (neutrophil collagenase); 25 µM inhibiting collagen synthesis by bovine articular chondrocytes cultured in alginate

Warning

Toxicity: Harmful & Carcinogenic / Teratogenic (E)

Reconstitution

Follwing reconstitution, refrigerate (4°C). Stock solutions are stable for up to 5 days at 4°C.

Other Notes

D’Agostino, P., et al. 1998. J. Infect. Dis. 177, 489.
Beekman, B., et al. 1997. Biochem. Biophys. Res. Commun. 237, 107.
Hanemaaijer, R., et al. 1997. J. Biol. Chem. 272, 31504.
Lauhio, A., et al. 1994. Clin. Exp. Immunol. Antimicrobiol. Agents Chemother. 36, 227.
Sorsa, T., et al. 1994. Ann. N.Y. Acad. Sci.732, 112.
Suomalainen, K., et al. 1992. Antimicrobiol. Agents Chemother.36, 227.

性质

安全信息

符号

  GHS07

信号词 Warning

危害声明 H302 - H315 - H319 - H335

警示性声明 P261 - P264 - P270 - P301 + P312 - P302 + P352 - P305 + P351 + P338

靶器官 Respiratory system

个人防护装备 dust mask type N95 (US), Eyeshields, Gloves

危害码 (欧洲) Xn

风险声明 (欧洲) 22-36/37/38

安全声明 (欧洲) 26

RIDADR NONH for all modes of transport

WGK德国 WGK 3

RTECS QI8925000